SS 22 - Phys 3: Biological Imaging

Monday, September 30, 2024

3:00 PM – 4:00 PM ET

Location: Room 145

AMA PRA Category 1 Credits 1.00

CAMPEP Credits: 1.00

MDCB Credits: 1.00

Moderator(s)

3:00 PM – 3:10 PM ET

Early Clinical Insights into FDG-Guided Radiotherapy Planning and Delivery on a Novel PET-Linac Platform in Patients with Lung and Bone Lesions: Pioneering Real-Time Biology-Guided Radiotherapy
Presenter: Bin Cai, PhD – University of Texas Southwestern Medical Center
3:10 PM – 3:20 PM ET

Toward Adaptive Dose Painting with Hypoxia Biomarkers: Feasibility of Oxygen-Enhanced (OE)-MRI T₁ Mapping on Low-Field MR-Linac
Presenter: Claire Park, PhD, BS – Memorial Sloan Kettering Cancer Center
3:20 PM – 3:30 PM ET

Pathologic Response Prediction Value of¹⁸f-Fapi PET/CT in ESCC Treated with Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
Presenter: Yuchun Wei, MD, PhD – Shandong Cancer Hospital and Institute
3:30 PM – 3:40 PM ET

Evaluating the Efficacy of Novel MET-Targeting Camelid Derived Antibody as an Imaging Agent in Head and Neck Cancers
Presenter: Rachel Minne, MS, BS – University of Wisconsin School of Medicine and Public Health
3:40 PM – 3:50 PM ET

APTw Imaging for Personalized Target Delineation of Glioblastoma
Presenter: Patrick Tang, MSc – Erasmus MC Cancer Institute
3:50 PM – 4:00 PM ET

Feasibility of Biology-Guided Radiotherapy with Gallium-68 PSMA-11 Radiotracer for Bony Metastases in Prostate Cancer Patients
Presenter: Chunhui Han, PhD – City of Hope National Medical Center